Emmanuelle Varon1, Robert Cohen2, Stéphane Béchet3, Catherine Doit4, Corinne Levy5. 1. Centre National de Référence des Pneumocoques, Laboratoire de Microbiologie, AP-HP, Hôpital Européen Georges Pompidou, Paris, France. 2. Université Paris Est, IMRB-GRC GEMINI, 94000 Créteil, France; GPIP, Groupe de Pathologie infectieuse Pédiatrique, Société Française de Pédiatrie, Nice, France; ACTIV, Association Clinique et Thérapeutique Infantile du val de Marne, Saint-Maur des Fossés, France; (54)CRC CHI Créteil, Créteil, France; Unité Court Séjour, Petits Nourrissons, Service de Néonatologie, Centre Hospitalier Intercommunal de Créteil, Créteil, France. 3. ACTIV, Association Clinique et Thérapeutique Infantile du val de Marne, Saint-Maur des Fossés, France; (54)CRC CHI Créteil, Créteil, France. 4. Univ Paris Diderot, Sorbonne Paris Cité, Paris, France; Service de Microbiologie, Hôpital Robert-Debré, 75019 Paris, France. 5. Université Paris Est, IMRB-GRC GEMINI, 94000 Créteil, France; GPIP, Groupe de Pathologie infectieuse Pédiatrique, Société Française de Pédiatrie, Nice, France; ACTIV, Association Clinique et Thérapeutique Infantile du val de Marne, Saint-Maur des Fossés, France; (54)CRC CHI Créteil, Créteil, France. Electronic address: corinne.levy@activ-france.fr.
Abstract
BACKGROUND: Changes in serotype distribution have been induced after pneumococcal conjugate vaccines (PCV) implementation, and non-vaccine serotypes are now circulating. Among these latter serotypes, we aimed to distinguish those with high invasive disease potential before (2008-2009) and after PCV13 implementation (2012-2013). METHODS: Invasive pneumococcal disease (IPD) serotypes isolated from children 6 to 24 months were compared with nasopharyngeal-colonizing serotypes in healthy children. To assess the invasive potential of a given serotype, odds ratios (ORs) were calculated. For each serotype, OR >1 indicated increased probability of association with IPD and OR <1 decreased probability. RESULTS: In 2008/2009 and 2012/2013, 355 pneumococci were isolated from 1212 healthy children and from 569 IPD, including 166 meningitis, 114 pneumonia, and 289 other IPDs. In period 1, serotypes 7F, 3, 1, 24F, and 19A showed highly significant invasive disease potential whereas in period 2, only serotype 24F was associated with a significant high OR (6.6 [95% CI 2.6; 16.2]). Of note, for serotype 12F, OR could not be calculated because of no carrier recorded, however, if there had been a single 12F carrier, the OR would be among the highest, in period 2, 15.7 [95% 3.4; 73.0]). Only two serotypes appeared negatively associated with IPD, 11A and 23B in the period 2 as compared with nine in period 1. In the second period, pneumococcal penicillin non-susceptible isolates were mostly represented by serotypes 19A, 15A, 19F, 35B and 24F both in carriers and IPD. Only one strain was resistant to penicillin with MIC=4 μg/ml (serotype 19A) during the first period. CONCLUSION: In children <2 years old, compared to the previous period, the number of serotypes having a high disease potential decreased after PCV13 implementation, only two non-vaccine serotypes, 24F and 12F, had high invasive disease potential.
BACKGROUND: Changes in serotype distribution have been induced after pneumococcal conjugate vaccines (PCV) implementation, and non-vaccine serotypes are now circulating. Among these latter serotypes, we aimed to distinguish those with high invasive disease potential before (2008-2009) and after PCV13 implementation (2012-2013). METHODS: Invasive pneumococcal disease (IPD) serotypes isolated from children 6 to 24 months were compared with nasopharyngeal-colonizing serotypes in healthy children. To assess the invasive potential of a given serotype, odds ratios (ORs) were calculated. For each serotype, OR >1 indicated increased probability of association with IPD and OR <1 decreased probability. RESULTS: In 2008/2009 and 2012/2013, 355 pneumococci were isolated from 1212 healthy children and from 569 IPD, including 166 meningitis, 114 pneumonia, and 289 other IPDs. In period 1, serotypes 7F, 3, 1, 24F, and 19A showed highly significant invasive disease potential whereas in period 2, only serotype 24F was associated with a significant high OR (6.6 [95% CI 2.6; 16.2]). Of note, for serotype 12F, OR could not be calculated because of no carrier recorded, however, if there had been a single 12F carrier, the OR would be among the highest, in period 2, 15.7 [95% 3.4; 73.0]). Only two serotypes appeared negatively associated with IPD, 11A and 23B in the period 2 as compared with nine in period 1. In the second period, pneumococcalpenicillin non-susceptible isolates were mostly represented by serotypes 19A, 15A, 19F, 35B and 24F both in carriers and IPD. Only one strain was resistant to penicillin with MIC=4 μg/ml (serotype 19A) during the first period. CONCLUSION: In children <2 years old, compared to the previous period, the number of serotypes having a high disease potential decreased after PCV13 implementation, only two non-vaccine serotypes, 24F and 12F, had high invasive disease potential.
Authors: C Hays; Q Vermee; A Agathine; A Dupuis; E Varon; C Poyart; M-C Ploy; J Raymond Journal: Eur J Clin Microbiol Infect Dis Date: 2016-12-20 Impact factor: 3.267
Authors: Alan Kaplan; Pierre Arsenault; Brian Aw; Vivien Brown; George Fox; Ron Grossman; Taj Jadavji; Craig Laferrière; Suzanne Levitz; Mark Loeb; Andrew McIvor; Christopher H Mody; Yannick Poulin; Marla Shapiro; Dominique Tessier; Francois Théorêt; Karl Weiss; John Yaremko; George Zhanel Journal: Can Fam Physician Date: 2019-09 Impact factor: 3.275
Authors: Feroze Ganaie; Karsten Maruhn; Chengxin Li; Richard J Porambo; Pernille L Elverdal; Chitrananda Abeygunwardana; Mark van der Linden; Jens Ø Duus; Carmen L Sheppard; Moon H Nahm Journal: J Clin Microbiol Date: 2021-06-18 Impact factor: 5.948